These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 62714)

  • 1. Fibroblast lysis by lymphocytes from normal persons and SLE patients on short-term cultures.
    Liburd EM; Pazderka V; Russell AS; Dossetor JB
    Immunology; 1976 Nov; 31(5):767-72. PubMed ID: 62714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic activity of rheumatoid and normal lymphocytes against allogeneic and autologous synovial cells in vitro.
    Griffiths MM; Smith CB; Ward JR; Klauber MR
    J Clin Invest; 1976 Sep; 58(3):613-22. PubMed ID: 956390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
    Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
    Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective depression of the xenogeneic cell-mediated lympholysis in systemic lupus erythematosus.
    Charpentier B; Carnaud C; Bach JF
    J Clin Invest; 1979 Aug; 64(2):351-60. PubMed ID: 110833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autochthonous, allogeneic, and exenogeneic cells as targets for vaccinia immune lymphocyte cytotoxicity.
    Woan MC; Yip DM; Tompkins WA
    J Immunol; 1978 Jan; 120(1):312-6. PubMed ID: 627720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-dependent direct cytotoxicity of human lymphocytes. I. Studies on peripheral blood lymphocytes and sera of patients with systemic lupus erythematosus.
    Scheinberg MA; Cathcart ES
    Clin Exp Immunol; 1976 May; 24(2):317-22. PubMed ID: 1084243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blocking effect of conditioned media from tumour cell cultures on the lysis of target cells by immune lymphocytes and macrophages.
    Lavrovsky VA; Tikhonov VJ; Rubzov NB; Razvorotnev VA
    Folia Biol (Praha); 1976; 22(2):101-7. PubMed ID: 1278566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
    Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
    J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector cell activity in antibody-mediated cell-dependent immune lympholysis. I. Normal individuals.
    Kovithavongs T; Hottman WC; Dossetor JB
    J Immunol; 1974 Oct; 113(4):1178-83. PubMed ID: 4413107
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte antigens in systemic lupus erythematosus: studies with heterologous antisera.
    Williams RC; Hughes GR; Snaith ML; Parry HF; Diao E; Greaves MF
    J Clin Invest; 1980 Feb; 65(2):379-89. PubMed ID: 6153183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
    Utsinger PD; Yount WJ
    J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.
    Lotze MT; Grimm EA; Mazumder A; Strausser JL; Rosenberg SA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4420-5. PubMed ID: 6975652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes.
    Perrin LH; Tishon A; Oldstone MB
    J Immunol; 1977 Jan; 118(1):282-90. PubMed ID: 830751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients.
    Lauwerys BR; Garot N; Renauld JC; Houssiau FA
    Arthritis Rheum; 2000 Sep; 43(9):1976-81. PubMed ID: 11014347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.
    Weill BJ; Renoux ML
    Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
    Kondo H; Rabin BS; Rodnan GP
    J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
    Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
    Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine marrow transplantation: are serum blocking factors necessary to maintain the stable chimeric state?
    Tsoi MS; Storb R; Weiden PL; Graham TC; Schroeder ML; Thomas ED
    J Immunol; 1975 Feb; 114(2 Pt 1):531-9. PubMed ID: 1091699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.